Technology Research Personalized Treatment Glucose Monitoring & Insulin Delivery Therapeutic Discovery and Development

AACE 2026: AI moves from hype to reality in diabetes care

April 23, 2026 By Matthew Solan 4 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
-0:00/0:00

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content